Mylan/Merck KGaA To Divest Five Generic Drugs To Clear Antitrust Hurdle For Acquisition
Amneal Pharmaceuticals is the beneficiary of FTC’s concerns about the sales power of the newly combined entity.
Amneal Pharmaceuticals is the beneficiary of FTC’s concerns about the sales power of the newly combined entity.